Israeli pharmaceutical company RedHill Biopharma has initiated a placebo-controlled Phase II trial to assess the combination ...

The six biggest myths about prostate cancer – as it is named England’s most common cancer - There has been a 25 per cent ...

IT’S a disease that only affects old men. Wrong. You won’t die of it, you die with it. Wrong again! Prostate cancer is the most common cancer in England, overtaking breast cancer for the first ...

New data showed that prior malignancy may influence survival outcomes in patients with metastatic colorectal cancer, ...

I was in a conversation with an elderly male relative recently and was shocked at the number of people we all know, some of them having been in government at the highest level, who succumbed to ...

(RTTNews) - RedHill Biopharma (RDHL) Tuesday announced that it has launched a Phase 2 trial to assess opaganib's ability to enhance darolutamide in treating metastatic castrate-resistant prostate ...

RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...

Advanced Imaging Uncovers Hidden Metastases in High-Risk Prostate Cancer Cases Jan. 3, 2025 — A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer ...

The incidence of advanced prostate cancer in California rose markedly in the decade since doctors stopped routinely screening all men for the disease, according to a new study.